SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Moon RT, Bowerman B, Boutros M, Perrimon N 2002 The promise and perils of Wnt signaling through beta-catenin. Science 296: 16441646.
  • 2
    Westendorf JJ, Kahler RA, Schroeder TM 2004 Wnt signaling in osteoblasts and bone diseases. Gene 341: 1939.
  • 3
    Hey PJ, Twells RC, Phillips MS, Yusuke N, Brown SD, Kawaguchi Y, Cox R, Guochun X, Dugan V, Hammond H, Metzker ML, Todd JA, Hess JF 1998 Cloning of a novel member of the low-density lipoprotein receptor family. Gene 216: 103111.
  • 4
    Dong Y, Lathrop W, Weaver D, Qiu Q, Cini J, Bertolini D, Chen D 1998 Molecular cloning and characterization of LR3, a novel LDL receptor family protein with mitogenic activity. Biochem Biophys Res Commun 251: 784790.
  • 5
    Kim DH, Inagaki Y, Suzuki T, Ioka RX, Yoshioka SZ, Magoori K, Kang MJ, Cho Y, Nakano AZ, Liu Q, Fujino T, Suzuki H, Sasano H, Yamamoto TT 1998 A new low density lipoprotein receptor related protein, LRP5, is expressed in hepatocytes and adrenal cortex, and recognizes apolipoprotein E. J Biochem (Tokyo) 124: 10721076.
  • 6
    Brown MS, Goldstein JL 1979 Receptor-mediated endocytosis: Insights from the lipoprotein receptor system. Proc Natl Acad Sci USA 76: 33303337.
  • 7
    Tamai K, Zeng X, Liu C, Zhang X, Harada Y, Chang Z, He X 2004 A mechanism for Wnt coreceptor activation. Mol Cell 13: 149156.
  • 8
    Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y, Hess F, Saint-Jeannet JP, He X 2000 LDL-receptor-related proteins in Wnt signal transduction. Nature 407: 530535.
  • 9
    Wehrli M, Dougan ST, Caldwell K, O'Keefe L, Schwartz S, Vaizel-Ohayon D, Schejter E, Tomlinson A, DiNardo S 2000 arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 407: 527530.
  • 10
    Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Rslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De PA, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van HW, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML 2001 LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107: 513523.
  • 11
    Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP 2002 High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346: 15131521.
  • 12
    Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van EP, Recker RR, Johnson ML 2002 A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70: 1119.
  • 13
    Van WL, Cleiren E, Gram J, Beals RK, Benichou O, Scopelliti D, Key L, Renton T, Bartels C, Gong Y, Warman ML, De Vernejoul MC, Bollerslev J, Van HW 2003 Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet 72: 763771.
  • 14
    Ai M, Heeger S, Bartels CF, Schelling DK 2005 Clinical and molecular findings in osteoporosis-pseudoglioma syndrome. Am J Hum Genet 77: 741753.
  • 15
    Kassem M 2004 Mesenchymal stem cells: Biological characteristics and potential clinical applications. Cloning Stem Cells 6: 369374.
  • 16
    Gimble JM, Zvonic S, Floyd ZE, Kassem M, Nuttall ME 2006 Playing with bone and fat. J Cell Biochem 98: 251266.
  • 17
    Simonsen JL, Rosada C, Serakinci N, Justesen J, Stenderup K, Rattan SI, Jensen TG, Kassem M 2002 Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 20: 592596.
  • 18
    Abdallah BM, Haack-Sorensen M, Burns JS, Elsnab B, Jakob F, Hokland P, Kassem M 2005 Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation. Biochem Biophys Res Commun 326: 527538.
  • 19
    Bollerslev J 1989 Autosomal dominant osteopetrosis: Bone metabolism and epidemiological, clinical, and hormonal aspects. Endocr Rev 10: 4567.
  • 20
    Bollerslev J, Marks SC, Pockwinse S, Kassem M, Brixen K, Steiniche T, Mosekilde L 1993 Ultrastructural investigation of bone resorptive cells in two types of autosomal dominant osteopetrosis. Bone 14: 865869.
  • 21
    Ai M, Holmen SL, Van HW, Williams BO, Warman ML 2005 Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling. Mol Cell Biol 25: 49464955.
  • 22
    Abdallah BM, Haack-Sorensen M, Fink T, Kassem M 2006 Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females. Bone 39: 181188.
  • 23
    Dosen G, Tenstad E, Nygren MK, Stubberud H, Funderud S, Rian E 2006 Wnt expression and canonical Wnt signaling in human bone marrow B lymphopoiesis. BMC Immunol 7: 13.
  • 24
    Etheridge SL, Spencer GJ, Heath DJ, Genever PG 2004 Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 22: 849860.
  • 25
    Brockstedt H, Bollerslev J, Melsen F, Mosekilde L 1996 Cortical bone remodeling in autosomal dominant osteopetrosis: A study of two different phenotypes. Bone 18: 6772.
  • 26
    Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C 1998 Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391: 357362.
  • 27
    Fedi P, Bafico A, Soria AN, Burgess WH, Miki T, Bottaro DP, Kraus MH, Aaronson SA 1999 Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling. J Biol Chem 274: 1946519472.
  • 28
    Gregory CA, Singh H, Perry AS, Prockop DJ 2003 The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem 278: 2806728078.
  • 29
    Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass DA, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L 2002 Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157: 303314.
  • 30
    Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, Bouxsein ML, Reddy PS, Bodine PV, Robinson JA, Bhat B, Marzolf J, Moran RA, Bex F 2003 High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 18: 960974.
  • 31
    Bennett CN, Longo KA, Wright WS, Suva LJ, Lane TF, Hankenson KD, MacDougald OA 2005 Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci USA 102: 33243329.
  • 32
    Morvan F, Boulukos K, Clement-Lacroix P, Roman RS, Suc-Royer I, Vayssiere B, Ammann P, Martin P, Pinho S, Pognonec P, Mollat P, Niehrs C, Baron R, Rawadi G 2006 Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 21: 934945.
  • 33
    Bain G, Muller T, Wang X, Papkoff J 2003 Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochem Biophys Res Commun 301: 8491.
  • 34
    Hu H, Hilton MJ, Tu X, Yu K, Ornitz DM, Long F 2005 Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132: 4960.
  • 35
    Zhang Y, Wang Y, Li X, Zhang J, Mao J, Li Z, Zheng J, Li L, Harris S, Wu D 2004 The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with Mesd. Mol Cell Biol 24: 46774684.
  • 36
    Ellies DL, Viviano B, McCarthy J, Rey JP, Itasaki N, Saunders S, Krumlauf R 2006 Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5(G171V) to modulate Wnt activity. J Bone Miner Res 21: 17381749.
  • 37
    Baek SH, Kioussi C, Briata P, Wang D, Nguyen HD, Ohgi KA, Glass CK, Wynshaw-Boris A, Rose DW, Rosenfeld MG 2003 Regulated subset of G1 growth-control genes in response to derepression by the Wnt pathway. Proc Natl Acad Sci USA 100: 32453250.
  • 38
    Kleber M, Sommer L 2004 Wnt signaling and the regulation of stem cell function. Curr Opin Cell Biol 16: 681687.
  • 39
    Boland GM, Perkins G, Hall DJ, Tuan RS 2004 Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 93: 12101230.
  • 40
    De BJ, Wang HJ, Van BC 2004 Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng 10: 393401.
  • 41
    Hartmann C, Tabin CJ 2000 Dual roles of Wnt signaling during chondrogenesis in the chicken limb. Development 127: 31413159.
  • 42
    Glass DA II, Karsenty G 2006 Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation. Ann N Y Acad Sci 1068: 117130.
  • 43
    Henriksen K, Gram J, Hoegh-Andersen P, Jemtland R, Ueland T, Dziegiel MH, Schaller S, Bollerslev J, Karsdal MA 2005 Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T253I mutation in low-density lipoprotein receptor-related protein 5 are normal in vitro, but have decreased resorption capacity in vivo. Am J Pathol 167: 13411348.
  • 44
    Robinson JA, Chatterjee-Kishore M, Yaworsky PJ, Cullen DM, Zhao W, Li C, Kharode Y, Sauter L, Babij P, Brown EL, Hill AA, Akhter MP, Johnson ML, Recker RR, Komm BS, Bex FJ 2006 Wnt/beta-catenin signaling is a normal physiological response to mechanical loading in bone. J Biol Chem 281: 3172031728.
  • 45
    Akhter MP, Wells DJ, Short SJ, Cullen DM, Johnson ML, Haynatzki GR, Babij P, Allen KM, Yaworsky PJ, Bex F, Recker RR 2004 Bone biomechanical properties in LRP5 mutant mice. Bone 35: 162169.
  • 46
    Johnson ML 2004 The high bone mass family-the role of Wnt/Lrp5 signaling in the regulation of bone mass. J Musculoskelet Neuron Interact 4: 135138.
  • 47
    Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M 2001 Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2: 165171.
  • 48
    Dong YF, Soung DY, Schwarz EM, O'keefe RJ, Drissi H 2006 Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. J Cell Physiol 208: 7786.
  • 49
    Kang S, Bennett CN, Gerin I, Rapp LA, Hankenson KD, MacDougald OA, 2007 WNT signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing c/EBPα and PPARγ. J Biol Chem 282: 1451514524.
  • 50
    Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA 2000 Inhibition of adipogenesis by Wnt signaling. Science 289: 950953.
  • 51
    Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, Johnson KW, Harrison SD, MacDougald OA 2002 Regulation of Wnt signaling during adipogenesis. J Biol Chem 277: 3099831004.
  • 52
    Liu J, Farmer SR 2004 Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes. J Biol Chem 279: 4502045027.
  • 53
    Christodoulides C, Laudes M, Cawthorn WP, Schinner S, Soos M, O'Rahilly S, Sethi JK, Vidal-Puig A 2006 The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis. J Cell Sci 119: 26132620.
  • 54
    Li J, Sarosi I, Cattley RC, Pretorius J, Asuncion F, Grisanti M, Morony S, Adamu S, Geng Z, Qiu W, Kostenuik P, Lacey DL, Simonet WS, Bolon B, Qian X, Shalhoub V, Ominsky MS, Zhu KH, Li X, Richards WG 2006 Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. Bone 39: 754766.
  • 55
    Li X, Liu P, Liu W, Maye P, Zhang J, Zhang Y, Hurley M, Guo C, Boskey A, Sun L, Harris SE, Rowe DW, Ke HZ, Wu D 2005 Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat Genet 37: 945952.